The down-regulation of Wnt/β-catenin signaling will bring about growth inhibition and metastasis decrease in the CSC of HNSCC, and the MET/FZD8 signaling axis will become precise therapeutic target of CSC of HNSCC [32]. Here, MET is linked to head and neck squamous cell carcinoma.